Murat Araz

37PUBLICATIONS

197CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyNutrigenomics and personalised nutrition

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (37)

Sort by Publication Date:

|Jun 26, 2026

Early PSA Decline Predicts Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Retrospective Single-Center Study.

|Jun 26, 2026

Prognostic Value of C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma.

|Jun 25, 2026

Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing Loss.

|May 27, 2026

Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions.

|May 27, 2026

Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

|Apr 01, 2026

Clinical impact of TP53 mutation status on survival outcomes in metastatic colorectal cancer.

Oğuzhan Yıldız, Hakan Şat Bozcuk, Melek Karakurt Eryılmaz

Pageof 7

Frequent Collaborators

20 joint publications

Mehmet Artaç

14 joint publications

Melek Karakurt Eryılmaz

11 joint publications

Mehmet Zahid Koçak

Oğuzhan Yıldız

Ali Fuat Gürbüz

Talat Aykut

İsmail Beypınar

Ahmet Oruç

Ömer Genç

Mustafa Korkmaz

Frequent Collaborators

20 joint publications

Mehmet Artaç

14 joint publications

Melek Karakurt Eryılmaz

11 joint publications

Mehmet Zahid Koçak

9 joint publications

Oğuzhan Yıldız